ECAT: Saba sells 49,369 shares at $16.30
BlackRock ESG Capital Allocation Term Trust (ECAT): Saba Capital Management, L.P., a 10% owner, reported open‑market sales of ECAT common stock.
Rhea-AI Filing Summary
BlackRock ESG Capital Allocation Term Trust (ECAT): Saba Capital Management, L.P., a 10% owner, reported open‑market sales of ECAT common stock. On November 4, 2025, it sold 3,600 shares at $16.30, and on November 5, 2025, it sold 49,369 shares at $16.30. Following the November 5 transaction, Saba reported 27,174,673 shares beneficially owned on an indirect basis.
Positive
- None.
Negative
- None.
Insights
Routine insider sale; large indirect stake remains.
Saba Capital Management, L.P. disclosed sales of ECAT common shares: 3,600 on Nov 4, 2025 at $16.30 and 49,369 on Nov 5, 2025 at $16.30. These are Form 4 reportable transactions by a 10% owner.
After the latter transaction, Saba reported beneficial ownership of 27,174,673 shares on an indirect basis. The filing does not change issuer capital; it reflects holder activity in the open market.
Actual market impact depends on trading volume and future holder decisions. Subsequent filings may provide additional updates on ownership levels.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 49,369 | $16.30 | $805K |
| Sale | Common Stock | 3,600 | $16.30 | $59K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital (10% owner) report in ECAT?
Were these direct or indirect holdings of ECAT?
What were the transaction dates for Saba Capital’s ECAT sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.